Efficient manufacturing system needed to lower cost of Monoclonal antibody therapy, says former ICMR DG Nirmal Ganguly
May 30, 2021
New Delhi [India], May 30 : The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment...